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Abstract 
Objective: To develop an auto-segmentation method for delineating the biological tumor volume 
of nasopharyngeal carcinoma from positron emission tomography images. Methods: A phantom 
consisting of a water tank with fixed background fluorodeoxyglucose [18F-FDG] activity and 
spheres with diameters ranging from 2.1 to 5 cm with varying activities of FDG were used to si-
mulate tumors of different sizes and FDG uptake. The phantom was scanned with a PET/CT scan at 
different sphere to background intensity ratios. An optimum fixed percentage threshold (FT) ap-
proach and a signal-to-background ratio (SBR) approach were developed to estimate the true size 
of the spheres from the PET images. Both approaches were further evaluated in patient images for 
validation. Twenty-two patients with NPC from stage T1 to T4 were included. The PET based bio-
logical tumor volumes (BTV) were delineated with both FT (BTVFT) and SBR (BTVSBR) approaches 
and compared with the gross tumor volume localized from MRI (GTVMR). The mean volumes of 
BTVFT and BTVSBR were compared and the degree of overlap between GTVMR and both BTVs was 
evaluated. Paired t-tests were used for statistical analysis. Results: The optimal FT value was 36.5% 
of maximal intensity, and SBR approach was represented by an inverse linear regression model. 
The estimated volume of spheres segmented by both approaches shows no significant difference 
from the true volume of spheres (p > 0.05), but the average absolute errors were smaller from SBR 
approach than FT approach (p = 0.008). GTVMR was larger than both BTVFT (p = 0.003) and BTVSBR 
(p < 0.009). The overlapping volume of BTVSBR with GTVMR is significantly larger than with BTVFT 
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(0.52 and 0.42 respectively, p < 0.0005). Conclusions: SBR approach is more feasible than FT ap-
proach to localize the BTV of NPC from FDG-PET image, and BTV might help to modify the extent of 
GTVMR for radiotherapy planning purpose. 
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1. Introduction 
Intensity-modulated radiotherapy (IMRT) is the state of the art treatment for head and neck cancers. The critical 
first step to implement IMRT requires an accurate delineation of the gross tumor volume (GTV). Anatomical 
information from computed tomography (CT) and magnetic resonance imaging (MRI) is widely used for tumour 
localization. The introduction of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) illustrates 
the biological activity of the tumor. This will add another dimension showing the biological activity within the 
anatomical extent of infiltration of tumor as defined by computed tomography (CT) and magnetic resonance 
imaging (MRI). However, the resolution of PET scan is poor and the exact boundaries of the tumor on PET im-
ages are difficult to define.  
In the past decade, different segmentation methods such as visual interpretation, thresholding methods, varia-
tional approaches, and other software-based approaches were developed to localize the biological tumor volume 
(BTV) from FDG-PET [1], and many studies had illustrated that the incorporation of this biological information 
in radiotherapy planning procedure would often lead to a change in the local extent of anatomical based GTV 
[2]-[6]. However, there is still no consensus on which segmentation method would best localize the primary tu-
mour [1] [7]. Among all, fixed threshold approach and adaptative threshold approach are most commonly ap-
plied in most of the tumours in the head and neck region, but as yet, it has not been applied in nasopharyngeal 
carcinoma (NPC). 
In this study, two phantom-based segmentation approaches including the optimum fixed percentage threshold 
(FT) approach and the signal-to-background ratio (SBR) approach were developed. The accuracy and feasibility 
of both approaches were evaluated based on the phantom studies and further validated in the patients’ images. 
Unlike other head and neck cancers, we cannot have actual measurement of the tumor since nasopharyngeal car-
cinoma is not treated surgically with resection. MRI shows the most accurate anatomical extent of the primary 
tumor and the gross tumor volume in nasopharynx as delineated on MRI (GTVMR) was used as the standard for 
comparison. The BTVs as delineated by fixed threshold (BTVFT) and SBR (BTVSBR) were compared with 
GTVMR for their difference in volumes and degree of overlap in anatomical position.  
2. Methods 
2.1. Phantom Study 
Two in-house produced phantoms (Phantom 1 and Phantom 2), consisting of 2 water tanks with width × length × 
height = 23 × 20 × 23 cm3, together with 7 difference sizes of glass spheres (5.2, 9.3, 16.0, 23.7, 37.4, 52.6 and 
68.1 cm3) with internal diameter ranged from 2.1 cm to 5 cm were developed. Each sphere was made with a sin-
gle-end opening, and with wall thickness of 2.5 - 3.0 mm. All the spheres were sealed with 18F-FDG solution at 
an activity concentration of 108 kBq/ml (±5%). They were immersed in the phantom pool which contained 
18F-FDG solution at a constant activity of 3.145 kBq/ml (±5%) (Figure 1). The spheres simulated tumor with 
different sizes and FDG uptake. While the activity of 18F-FDG inside the spheres decayed, PET/CT images 
were acquired at 9 different sets of sphere to background intensity ratios (33, 24, 16, 12, 8.5, 6, 5, 4 and 2). A 
combined PET/CT helical mode scanner (Discovery VCT; GE Medical Systems) was used to acquire the images. 
PET/CT images were reconstructed at 0.625 mm intervals. The reconstructed field of view (FOV) is 35 cm, with 
512 × 512 matrix size. The images were transferred to MIMcontouring Advanced—MIMTM 5 (MIM Software 
Inc.) for analysis. 
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Figure 1. The diagram shows different sizes of glass spheres placed inside phantom 1 
& 2. They are positioned with at least 4 cm apart from each other inside the phantom.    
2.2. Fixed Threshold Approach 
Threshold of 38% maximal standardized uptake value (SUV) was first selected for estimation of the volume of 
sphere as derived from the PET images. This value was iteratively tested for less than 6 times with step size 
equal 0.5% until the resultant volume of sphere has the least square difference with the true volume of sphere. 
The true volume of each sphere was calculated from the volume as outlined from CT images. After all, the 
measured values from all spheres were averaged to get the optimum fixed percentage threshold value.  
2.3. Signal to Background Approach 
A varying threshold value which relies on the relationship between the percentage threshold values and the 
measured sphere to background intensity ratios were derived to aid lesion segmentation. In this model, the per-
centage threshold value was determined as a percentage of the maximal activity within the spheres located from 
PET images. The maximum radioactivity of the sphere was the hottest area (16 mm diameter) drawn on the 
transverse slice of the PET image. The average background activity was measured from the 18F-FGD activity in 
each set of phantom pool. Four circles with 20 mm diameter were drawn across each slice with 1 cm apart from 
the sphere, and without overlapping with each other. The average background activity was then collected from a 
total of 112 circles drawn at each phantom pool. When both the maximum activity and the mean background ac-
tivity were collected, the intensity ratios for each couple of sphere to background were obtained. The measured 
SBR and the resultant threshold are fitted by a regression function to yield the best regression parameters for the 
equation.  
After both approaches were developed, they were first used to re-segment the spheres. The estimated volumes 
derived from both approaches were validated with the true volume of spheres. Paired t-test using SPSS® (version 
17.0) was applied for statistical analysis. 
2.4. Validation in Patients’ PET Images 
After the phantom studies, both approaches were validated with patients’ images. A cohort of 22 nasopharyngeal 
carcinoma patients, 16 male and 6 female, who had PET/CT and MRI scan performed in treatment position for 
IMRT planning during 2008-2009 were included. The group included 8 patients each with stage T1 and T3, and 
3 patients each with T2 and T4 respectively. All patients had their planning PET/CT, and MRI done not more 
than one week apart. The scanning parameters for PET/CT were 140 kV, auto mA (150 - 350 mA), with slice 
interval at 2.5 mm. Reconstructed FOV was 35 cm, with 512 × 512 matrix sizes. For PET scan, the FOV was 70 
cm, with 128 × 128 matrix sizes. The slice was reconstructed at 3.25 mm interval. The coverage of both PET 
and CT scans begins from 1 cm above the vertex to 1/3 of upper thigh. MRI was performed using 3T MRI (Phi-
lips Achieva 3.0 system). Images were acquired from vertex to clavicle region. FOV was 50 cm, with 560 × 560 
matrix sizes. The slice thickness was reconstructed at 3 mm interval.  
Patient’s position during PET/CT and MRI were the same. Each patient was lying on a headrest, and cast was 
used to immobilize the patient only in PET/CT. All the images were fused manually based on some prominent 
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anatomical position, such as the divergence of basilar artery, lens and dens etc., before radiotherapy planning. In 
this study, a clinical oncologist was asked to localize the GTVMR without looking at the tumour from the PET/ 
CT. Meanwhile, the BTVs were outlined by an experienced radiation therapist using the FT and SBR segmenta-
tion approaches as derived from the phantom study. The mean volume of GTVMR and both BTVs, BTVFT and 
BTVSBR, as well as the overlapping and non-overlapping fraction between GTVMR and BTVs were compared as 
shown in Figure 2. This includes the fraction of GTVMR enclosed within the BTV relative to GTVMR (OFMR), 
the fraction of BTV enclosed within the GTVMR relative to BTV (OFPET), the fraction of GTVMR excluded out-
side the BTV relative to GTVMR (1-OFMR), and also the fraction of BTV excluded outside the GTVMR relative to 
BTV (1-OFPET). Paired t-test and confidence interval was used for statistical analysis. 
3. Results 
55 out of 63 couples of sphere to background intensity ratio were measured. When the sphere to background in-
tensity ratio was less than 4, the lesions could not be differentiated from its background and the percentage 
threshold value could not be measured. Thus, 8 measurements could not be obtained and excluded from study. 
From the FT approach, the trend of the percentage threshold values appeared quite constant (Figure 3) between 
the spherical volume from 5.2 cm3 to 68.1 cm3 and within the sphere to background intensity ratio from 4 to 33. 
The threshold values varied from 31.8% to 41.5% (SD = 2.4%) with an average value equal to 36.5% of maxim-
al intensity uptake.  
For SBR approach, an inverse function was found between the threshold values and the SBR. The regression 
model was defined as  
( )Threshold % SBRa b= + , 
with the regression parameters a = 31.79 and b = 36.54 (R2 = 0.735) best fitted the experimental results (Figure 
4). The plots were valid with spherical volume ranges from 5.2 cm3 to 68.1 cm3, and with the measured sphere 
to background intensity ratio from 2.6 to 31.3.  
From the phantom’s images analysis, the estimated BTV derived from FT approach (BTVFT) and SBR ap-
proach (BTVSBR) were of no significant difference from the true volume of spheres (FT: p = 0.088; SBR: p = 
0.714). The true volume of spheres, which are the actual volume contain in each sphere, has less than 1% devia-
tion from the volume as outlined from CT images. However, the absolute differences between the estimated vo-
lume and the true volume of spheres derived from SBR approach was significantly less than that derived by FT 
approach (p = 0.008). A larger absolute error was commonly found in the smallest size (5.2 cm3) of sphere 
(Figure 5), the difference was 13.3% and 8.5% respectively for FT and SBR approach. 
From the patients’ images analysis, 18 out of 22 patients were available for validation. Four patients with 
stage T1 disease were excluded because both segmentation approaches failed to differentiate the edge of tumour 
from its background tissues. Their GTVMR ranged from 0.52 cm3 to 5.11 cm3 with an average volume equal to 
1.71 cm3. Two patients with T4 disease has the GTVMR 1.4 and 2.5 times greater than the largest size of our 
 
 
Figure 2. A schematic diagram describing the volume analysis between the overlap-
ping fraction and non-overlapping fraction of GTVMR and BTV.                      
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Figure 3. A schematic diagram describing the volume analysis between the overlapping frac-
tion and non-overlapping fraction of GTVMR and BTV.                                   
 
 
Figure 4. Relationship between the sphere to background ratio and the threshold activity to 
apply to adequately segment the spheres of volumes ranging from 5.2 to 68.1 cm3.                     
 
glass sphere used, however, it was expected that threshold measurement is insensitive to large volume, thus they 
were also included in the study group. The average volume of GTVMR, BTVFT and BTV SBR were 38.22 cm3, 
17.61 cm3, and 21.23 cm3 respectively. GTVMR was significantly larger than BTVFT (p = 0.003) and BTVSBR (p < 
0.009). As the average BTVSBR was larger than BTVFT, the average volume of overlapping between GTVMR 
with BTVSBR was also larger than with BTVFT, they were 18.65 cm3 and 16.1 cm3, respectively (p < 0.0005).  
The result of overlap analysis (Table 1) indicated that the percentage of volume overlapping between BTV 
and GTVMR relative to GTVMR increased significantly when the segmentation approach was changed from FT to 
SBR, the increment was from 42% to 52% (p = 0.018). Meanwhile, the percentage of BTV overlapping with 
GTVMR only reduced slightly from 89% to 84%. On the other hand, there were almost half the volume of 
GTVMR excluded outside the BTV, whereas, there were 11% - 16% of BTV excluded outside GTVMR. 
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Table 1. A summary of mean overlapping fraction of volume between GTVMR and BTVFT or BTVSBR with 95% confidence 
interval.                                                                                                 
Stage  Mean OFMR Mean OFPET Mean 1 - OFMR Mean 1 - OFPET 
1-4 
BTVFT 95% CI 0.42 (0.36 - 0.48) 0.89 (0.83 - 0.95) 0.58 (0.523 - 0.64) 0.11 (0.05 - 0.17) 
BTVSBR 95% CI 0.52 (0.45 - 0.58) 0.84 (0.78 - 0.9) 0.48 (0.42 - 0.55) 0.16 (0.1 - 0.22) 
 
 
Figure 5. The mean absolute relative difference of the estimated volume of spheres. The above 
T-bar is for (+) 95% CI. ● by FT approach; ∆ by SBR approach.                            
4. Discussion 
The results of volume analysis on phantom’s images reflected the SBR approach is more accurate than the FT 
approach. The SBR approach shows a significantly smaller average absolute error in volume estimation (p = 
0.008). There is an inverse correlation between the average relative error in volume estimation versus both the 
size and signal to background intensity ratio. The results were accounted by the limitation of intrinsic spatial 
resolution of PET, the associated partial volume effect and also edge-blurring effect. Previous studies had indi-
cated that partial volume effect often existed when the lesion was less than 5 cm3 [8] [9], and the edge blurring 
effect was dominant when the background contrast level was less than 5 [10]. These errors may account for the 
failure of lesion segmentation when the sphere to background intensity ratio was below 4.  
Previous researchers had stated that fixed threshold approach is easy to apply for delineation, but it should be 
validated or otherwise it might lead to significant errors in volume estimation [4] [11] [12]. Our study demon-
strated that SBR approach is more accurate than a calibrated fixed percentage threshold for lesion segmentation 
because SBR approach is relatively more flexible to include the FDG avid voxels in the segmentation process. 
The potential limitation in this phantom study was mainly the use of glass sphere which may affect the threshold 
findings by shifting of gradient peak towards the interior of the sphere, thus causing the measured threshold 
values to be underestimated [13].  
From patients’ images study, the mean GTVMR was larger than the mean BTVFT by 2.2 folds and BTVSBR by 
1.8 folds. This was consistent with previous findings, in which the CT or MRI based GTV in most of the head 
and neck tumours were usually larger than the BTV by not more than 2 folds [2]-[5] [14] [15]. Danise et al. 
(2004) [2] reported that the manually localized GTV was 1.6 times larger than the BTV, but the BTV had the 
closest tumour size when compared with the standard pathological specimen. The authors concluded that BTV, 
which segmented by its institutional-based SBR model, was more accurate than anatomical based GTV to reflect 
the tumour extension of laryngeal cancer. Although pathological specimens of NPC were not available for anal-
ysis, our findings using MR detected GTV were similar to findings for other head and neck cancers. The almost 
double in size of GTVMR over BTV accounted for an average of 58% and 48% of GTVMR excluded from BTVFT 
and BTVSBR respectively. The difference in tumour extent between GTVMR and BTVFT or BTVSBR was clearly 
demonstrated in Figure 6 & Figure 7. In Figure 6, there is a tail-like structure of GTVMR outlined on the left 
side of nasopharynx, but no radioactive glucose uptake was reflected on the same area from the FDG-PET im-
age. In Figure 7, the sphenoid and ethmoid sinus involvement outlined from MRI was obviously more than it 
was detected from PET/CT image.  
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Figure 6. Comparison of GTVMR (red), BTVFT (green) and BTVSBR (blue) for a stage 
T2 NPC. MRI and PET/CT was first registered, and then MR based GTV (left) was 
pasted to the fused PET image (right). Part of the GTVMR did not show any FDG up-
take with a tail-like structure extended outside the BTVs.                           
 
 
Figure 7. Comparison of GTVMR (red), BTVFT (green) and BTVSBR (blue) for a stage 
T4 NPC. After MRI was registered with PET/CT, GTVMR was pasted to PET/CT. 
Manually localized GTVMR may over-estimated the ethmoid sinus involvement, while 
under-estimated the intracranial involvement on the right side.                       
 
On the other hand, our results showed that there was up to an average of 84% BTVSBR and 89% BTVFT 
mapped within GTVMR, while there were 11% - 16% of BTV excluded outside the GTVMR. This reflected that 
when the thresholding approaches, particularly the SBR approach, was used to localized BTV from FDG-PET, it 
does not only have a high concordance with GTVMR, but also detect a significant portion of tumour involvement 
that might be underestimated from anatomical based information. An example was shown in Figure 7. BTV 
showed a larger extent of right temporal lobe involvement than it was localized in MRI based GTV. Although, 
Ng et al. (2009) [12] concluded that PET/CT is less sensitive than MRI to access the local extent of NPC when 
50% fixed threshold was used for BTV delineation. Our results suggested that different segmentation approach-
es would alter the tumour extent from FDG-PET image, and PET/CT has its specificity and sensitivity over MRI 
to detect the local tumour extent of NPC, provided that an appropriate segmentation approach was applied for 
the delineation of BTV. 
There are 4 out of 8 cases of stage T1 disease excluded in this study. These cases were commonly found to 
have a poor FDG uptake in the primary lesion but with a relatively higher FDG uptake in the tissues nearby, 
such as in soft palate, tongue, and pharyngeal constrictor muscle. The measured tumour to background intensity 
ratio was ranged from 2.7 to 4.5. This low contrast situation limits both the FT and SBR approaches to differen-
tiate the metabolically active tumour cells from their backgrounds, and this phenomenon were also reported in 
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some previous findings [16]-[18]. 
While there were no pathological specimen available to correlate with the image findings, it would be difficult 
to conclude whether GTVMR or BTVSBR could more truly reflect the local tumour extent. It is not sure if the 
GTVMR that is not included in BTV were due to microscopic extension of tumor with lesser proliferative activity 
or if the MR changes could be due to tissues inflammation, edema or even observer-based variability. On the 
other hand, the portion of BTV extending outside GTVMR could be due to infections, inflammation, or physio-
logically increased uptake in nearby tissue structures such as tonsils, salivary glands and muscles or partial vo-
lume effect. These possibilities should be considered on individual basis when interpreting the images. Our 
findings suggested that the biological information from FDG-PET would help to refine anatomical based GTV, 
and the change in local tumour extent would consequently lead to a change in radiation beam arrangement or the 
management approach as well [19]-[21].  
As a whole, SBR approach is more feasible than FT approach to outline BTV of NPC from FDG-PET. How-
ever, SBR approach has its own intrinsic limitations. The validation was limited to fixed size of spheres and 
homogenous activity, it does not take into account the irregular shape of tumour, the heterogeneity of tumour, 
and also the possibility of overlapping between the tumour and the surrounding normal tissues, thus causing un-
der/over estimating the tumour extent [1] [2] [4] [13]. Secondly, this tool needs to be calibrated to specific insti-
tutional image acquisition and reconstruction settings. And last but not the least, it is not ideal for low SBR im-
ages [2] [5] [13]. The sample size in this study was small and further study with larger cohort of patients with 
different T stage of disease would be required for validation of the SBR approach.  
5. Conclusion 
This study has demonstrated that SBR approach works better than FT approach to delineate BTV of NPC from 
FDG-PET, and this added on biological information would help to improve the tumour localization by minimiz-
ing the chance of over/under estimation of anatomical based GTV in radiotherapy planning procedure.  
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